GL1X · GenesisL1 explorer

Research workbench

The novel SUV4-20 inhibitor a-196 verifies a role for epigenetics in genomic integrity

Analyse The novel SUV4-20 inhibitor a-196 verifies a role for epigenetics in genomic… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5CPR
Type
protein
Length
232 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase SUV420H1
EC
2.1.1.43
UniProt
Q4FZB7
Ligands
SAM, 539, ZN
Pockets
3 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BHistone-lysine N-methyltransferase SUV420H1 (EC 2.1.1.43)protein23238% helix, 22% strandQ4FZB7

Ligands and binding sites

  • SAM · S-adenosylmethionine · ligand · chains B
  • 539 · 6,7-dichloro-N-cyclopentyl-4-(pyridin-4-yl)phthalazin-1-amine · ligand · chains B
  • ZN · Zinc ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13840.680.8139SAM, 539
2770.330.7418empty
3720.300.7316empty

Compared structures

  • 5CPR · The novel SUV4-20 inhibitor A-196 verifies a role for epigenetics in genomic integrity · the same entry in another collection · chain B against B, TM-score 1.00
  • Q4FZB7 · AlphaFold monomer V2.0 prediction for histone-lysine N-methyltransferase KMT5B (Q4FZB7) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.